Health In Tech (HIT) Q2 2026 Earnings Call Transcript
Health In Tech (HIT) reported Q2 2026 revenue of $8.1M, down 13.5% YoY due to policy timing shifts. Distribution partners grew 19.9% to 933. Contracted revenue was $32.3M, with $14M expected in H2 2026. Pipeline revenue reached $66.3M. Adjusted EBITDA was -$1.3M, and net loss was $2.5M. Management reaffirmed full-year guidance of $45M-$50M revenue, citing strong pipeline visibility. The company is investing in sales, marketing, and technology upgrades, including the upcoming HitRix platform for






